AAA

Affinity Asset Advisors Portfolio holdings

AUM $1.39B
1-Year Est. Return 230.19%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+230.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.39B
AUM Growth
+$317M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
118
New
Increased
Reduced
Closed

Top Buys

1
+$34.5M
2
+$28M
3
+$19.1M
4
ROIV icon
Roivant Sciences
ROIV
+$17.8M
5
FBRX icon
Forte Biosciences
FBRX
+$17.3M

Top Sells

1
+$66.7M
2
+$56.3M
3
+$42.8M
4
MRUS
Merus
MRUS
+$26.9M
5
SLNO icon
Soleno Therapeutics
SLNO
+$13.5M

Sector Composition

1 Healthcare 96.69%
2 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CATX icon
76
Perspective Therapeutics
CATX
$609M
$825K 0.06%
300,000
MGNX icon
77
MacroGenics
MGNX
$123M
$780K 0.06%
+484,308
PCSC
78
Perceptive Capital Solutions
PCSC
$139M
$652K 0.05%
50,000
-300,000
XFOR icon
79
X4 Pharmaceuticals
XFOR
$297M
$580K 0.04%
+145,000
QTTB icon
80
Q32 Bio
QTTB
$60.9M
$92.2K 0.01%
27,777
ADGM
81
Adagio Medical Holdings
ADGM
$22M
$83.2K 0.01%
80,000
RCKTW icon
82
Rocket Pharmaceuticals Warrant
RCKTW
$3.05M
$1.82K ﹤0.01%
75,000
ABUS icon
83
Arbutus Biopharma
ABUS
$898M
– –
0
AKBA icon
84
Akebia Therapeutics
AKBA
$334M
– –
-2,450,000
ATXS
85
DELISTED
Astria Therapeutics
ATXS
– –
-300,000
AUTL
86
Autolus Therapeutics
AUTL
$444M
– –
-1,750,000
CNTX icon
87
Context Therapeutics
CNTX
$210M
– –
-402,653
ELVN icon
88
Enliven Therapeutics
ELVN
$1.75B
– –
-400,000
EXEL icon
89
Exelixis
EXEL
$10.7B
– –
0
CBIO
90
Crescent Biopharma
CBIO
$341M
– –
-17,998
IBB icon
91
iShares Biotechnology ETF
IBB
$8.61B
– –
0
INSP icon
92
Inspire Medical Systems
INSP
$1.85B
– –
-50,000
JAZZ icon
93
Jazz Pharmaceuticals
JAZZ
$11.7B
– –
-25,000
MIST icon
94
Milestone Pharmaceuticals
MIST
$147M
– –
-666,666
MNPR icon
95
Monopar Therapeutics
MNPR
$357M
– –
-79,483
MRUS
96
DELISTED
Merus
MRUS
– –
-285,769
NTLA icon
97
Intellia Therapeutics
NTLA
$1.79B
– –
0
OCUL icon
98
Ocular Therapeutix
OCUL
$2.39B
– –
-239,000
OLMA icon
99
Olema Pharmaceuticals
OLMA
$1.93B
– –
-250,000
OMER icon
100
Omeros
OMER
$849M
– –
0
1 2 3
4
5